Literature DB >> 16483744

No significant association of the 5' end of neuregulin 1 and schizophrenia in a large Danish sample.

Andrés Ingason1, Karen Søeby, Sally Timm, August G Wang, Klaus D Jakobsen, Anders Fink-Jensen, Ralf Hemmingsen, Henrik Berg Rasmussen, Thomas Werge.   

Abstract

Neuregulin 1 has been implicated as a susceptibility gene in schizophrenia. Several research groups have reported association with the 5' end of the gene although no causative variant has been reported. We have investigated whether there is association with the 5' end of the gene in Danish schizophrenia patients. We found that the at-risk haplotype initially reported in the Icelandic population was not found in significant excess (or = 1.4, p = 0.12). The haplotype structure in the Danish sample was similar to that of other reported in other Caucasian populations and highly different from that of Chinese.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483744     DOI: 10.1016/j.schres.2005.12.850

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Authors:  Emily Moon; Brandi Rollins; Andrea Mesén; Adolfo Sequeira; Richard M Myers; Huda Akil; Stanley J Watson; Jack Barchas; Edward G Jones; Alan Schatzberg; William E Bunney; Lynn E DeLisi; William Byerley; Marquis P Vawter
Journal:  Schizophr Res       Date:  2011-07-13       Impact factor: 4.939

Review 3.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

4.  Neuregulin-1 genotypes and eye movements in schizophrenia.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Andres Ingason; Samuel B Hutton; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-03       Impact factor: 5.270

5.  Neuregulin 1 genotype and schizophrenia.

Authors:  Marcus R Munafò; Angela S Attwood; Jonathan Flint
Journal:  Schizophr Bull       Date:  2007-11-20       Impact factor: 9.306

6.  Family-based association study of Neuregulin 1 with psychotic bipolar disorder.

Authors:  Fernando S Goes; Virginia L Willour; Peter P Zandi; Pamela L Belmonte; Dean F MacKinnon; Francis M Mondimore; Barbara Schweizer; Elliot S Gershon; Francis J McMahon; James B Potash
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

7.  Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition.

Authors:  L Elliot Hong; Ikwunga Wonodi; O Colin Stine; Braxton D Mitchell; Gunvant K Thaker
Journal:  Biol Psychiatry       Date:  2007-07-12       Impact factor: 13.382

Review 8.  Nature and nurture in neuropsychiatric genetics: where do we stand?

Authors:  Danielle M Dick; Brien Riley; Kenneth S Kendler
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  A Study of the Association between SNP8NRG241930 in the 5' End of Neuroglin 1 Gene with Schizophrenia in a Group of Iranian Patients.

Authors:  Seyed Ali Mohamad Shariati; Mehrdad Behmanesh; Hamid Galehdari
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

Review 10.  BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.

Authors:  Zhengrong Zhang; Jing Huang; Yong Shen; Rena Li
Journal:  Front Mol Neurosci       Date:  2017-09-25       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.